Summary
- As of April 5, Pfizer Inc (PFE) shares closed at $42.99.
- Supported by large share repurchases, Pfizer share price has shown steady growth, from ~$25 in 2012 to the current level.
- The steady share price growth, and regular increasing dividend payments, have provided solid, stable returns for investors over the last 6 years.
- The only way an investor can realize a return from an investment in shares is through receipt of dividends, and/or gains on sales. I repeat - the only way.
- Analysts' Corner proprietary 1View?Scenarios™ dashboards are used to assess whether investors in Pfizer can reasonably expect to enjoy returns in the future, similar to those available over the last six years.
- This idea was discussed in more depth with members of my private investing community, Analysts Cnr | H2 SuperGrid. Start your free trial today »
Pfizer Inc: Investment Thesis
Source: Pfizer Inc
